In this video, Susana M. Campos, MD, MPH, discusses results from a single-arm phase 2 study of the concurrent treatment of vulvar cancer with chemoradiation and pembrolizumab.Patients who underwent ...

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Senator, Dr. Rasha Kelej, CEO of Merck Foundation and One of the Most Influential African Women for Six Consecutive Years ...

The global allergic rhinitis market is poised for substantial growth from 2025 to 2035, driven by a rise in allergic diseases, and advancements in th ...

(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the appointment of Marjorie Green to its Board of Directors, effective June 19, 2025.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that scientific and commercial team ...

Big pharma competes bitterly with the tech giants for the title of most dodgy corporate sector in the world. Given this ...

The company has raised its payouts for 14 consecutive years, and its nearly 89% growth over the last 10 years provides a ...

Corrections & Amplifications for the edition of June 24, 2025 ...

Merck & Co. Inc. closed 40.46% short of its 52-week high of $134.63, which the company reached on June 25th.

Kinetic measures of a cerebrospinal fluid (CSF) biomarker test predicted cognitive decline in Parkinson's disease and ...

Only last month, the Massachusetts-based company was outlining plans to lay off half of its employees in order to focus its ...